Scholarlink

Abstract <p>Brucellosis, caused by bacteria of the genus <i>Brucella</i>, is a globally prevalent zoonotic disease that poses serious risks to both animal and human health. <i>Brucella abortus</i> releases the biological nanoparticles (outer-membrane-vesicles, OMVs), which contribute to chronic infection by promoting host invasion and immune evasion. In this study, we performed a detailed characterization of OMVs derived from the wild-type <i>B. abortus</i> strain. These OMVs enhanced bacterial invasion and intracellular survival in macrophages ex vivo and increased pathogenicity in mice by modulating macrophage polarization in vivo. However, native OMVs showed low yield and limited immunogenicity. To overcome these limitations, we engineered a recombinant <i>B. abortus</i> strain Bru-M3, by deleting the <i>eipB</i>, <i>per</i>, and <i>wadC</i> genes (<i>Brucella abortus</i><sub>∆<i>eipB</i>∆<i>per</i>∆<i>wadC</i></sub>), which remodels noncanonical lipopolysaccharide (LPS). The Bru-M3 strain produced OMVs (OMV<sub>Bru−M3</sub>) at significantly higher yields and with enhanced immunogenicity. Immunization of mice via subcutaneous or intranasal routes with OMV<sub>Bru−M3</sub> conferred better effective protection against both low and high-dose intraperitoneal challenges with wild-type <i>B. abortus</i>. Vaccination with OMV<sub>Bru−M3</sub> also elicited stronger humoral responses and IFN-γ–producing Th1 CD4⁺ T cells, resulting in improved bacterial clearance, reduced tissue damage, and elevated inflammatory cytokine production compared to OMVs from wild-type <i>B. abortus</i>. These findings support the potential of OMV<sub>Bru−M3</sub> as a promising candidate for brucellosis vaccine development.</p> Graphic abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Biological nanoparticles from Brucella abortusΔeipB∆perΔwadC elicit protective immunity against brucellosis

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月21日

查看全文
  • Yike Huang,
  • Hengtai Wang,
  • Xiaowei Peng,
  • Tianpeng Li,
  • Xuezheng Fan,
  • Qingchun Shen,
  • Guangzhi Zhang,
  • Qianlin Li,
  • Pascal Boireau,
  • Hui Jiang,
  • Jiabo Ding,
  • Peng Li

摘要

Abstract

Brucellosis, caused by bacteria of the genus Brucella, is a globally prevalent zoonotic disease that poses serious risks to both animal and human health. Brucella abortus releases the biological nanoparticles (outer-membrane-vesicles, OMVs), which contribute to chronic infection by promoting host invasion and immune evasion. In this study, we performed a detailed characterization of OMVs derived from the wild-type B. abortus strain. These OMVs enhanced bacterial invasion and intracellular survival in macrophages ex vivo and increased pathogenicity in mice by modulating macrophage polarization in vivo. However, native OMVs showed low yield and limited immunogenicity. To overcome these limitations, we engineered a recombinant B. abortus strain Bru-M3, by deleting the eipB, per, and wadC genes (Brucella abortus∆eipB∆per∆wadC), which remodels noncanonical lipopolysaccharide (LPS). The Bru-M3 strain produced OMVs (OMVBru−M3) at significantly higher yields and with enhanced immunogenicity. Immunization of mice via subcutaneous or intranasal routes with OMVBru−M3 conferred better effective protection against both low and high-dose intraperitoneal challenges with wild-type B. abortus. Vaccination with OMVBru−M3 also elicited stronger humoral responses and IFN-γ–producing Th1 CD4⁺ T cells, resulting in improved bacterial clearance, reduced tissue damage, and elevated inflammatory cytokine production compared to OMVs from wild-type B. abortus. These findings support the potential of OMVBru−M3 as a promising candidate for brucellosis vaccine development.

Graphic abstract